Xilio Therapeutics Inc.
(XLO)
undefined
undefined%
At close: undefined
1.00
1.94%
After-hours Dec 13, 2024, 07:50 PM EST
Xilio Therapeutics Inc. Forcast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for XLO stock have an median target of 4, with a low estimate of 4 and a high estimate of 4. The median target predicts an increase of 308.16% from the current stock price of 0.98.
Analyst Consensus: Buy
AI Analyst Report
According to 1 stock analyst, the rating for Xilio Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
6.65M
from 0
Increased by -%
Revenue Next Year
32.73M
from 6.65M
Increased by 392.1%
EPS This Year
-1.26
from -2.78
Increased by 54.7%
EPS Next Year
-0.42
from -1.26
Increased by 66.7%